Article Information
History
- January 19, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Martin Philpott1,2,
- Jonathan Watson3,
- Anjan Thakurta2,3,4,
- Tom Brown Jr5,
- Tom Brown Sr5,6,
- Udo Oppermann1,2,7,* and
- Adam P Cribbs1,2,*
- 1Botnar Research Centre, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, National Institute of Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford OX3 7DQ, United Kingdom
- 2Oxford Centre for Translational Myeloma Research Oxford, Oxford OX3 7DQ, United Kingdom
- 3Radcliffe Department of Medicine, Oxford University
- 4Bristol Myers Squibb, Translational Development and Diagnostics, Summit, NJ, USA
- 5ATDBio Ltd, Building 30, School of Chemistry, University of Southampton, United Kingdom, SO17 1BJ
- 6Department of Chemistry, University of Oxford, Chemistry Research Laboratory, 12 Mansfield Road, Oxford, OX1 3TA, United Kingdom Structural Genomics Consortium, University of Oxford, Oxford OX3 7LD, United Kingdom
- 7Centre for Medicines Development, University of Oxford
- ↵*Corresponding authors: adam.cribbs{at}ndorms.ox.ac.uk, udo.oppermann{at}ndorms.ox.ac.uk
Posted January 19, 2021.
Highly accurate barcode and UMI error correction using dual nucleotide dimer blocks allows direct single-cell nanopore transcriptome sequencing
